Biopharma Services USA
- UEI
- DRLXCANKKNN6
- CAGE
- 7G0A9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$1 |
| FY2023 | $279,056 |
Contract awards
Quick answers
Is Biopharma Services USA registered in SAM.gov?
Biopharma Services USA's SAM.gov registration expired on July 5, 2023.
How much has Biopharma Services USA received in federal contracts?
Federal contracts obligated $279,055 to Biopharma Services USA in fiscal years 2023 through 2027.
What is Biopharma Services USA's most recent federal award?
Biopharma Services USA's most recent federal contract award is New task order under IDIQ contract HHSF223201610004I entitled, "a randomized, open label, two treatment, four period… (75F40120F19005), from Food and Drug Administration, on March 10, 2020.
On GovTribe
See Biopharma Services USA's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors